Chronic autoimmune condition that results in the fibrosis and destruction of intra-hepatic and extra-hepatic bile ducts
Aetiology
- 80% have associated IBD (more likely to be UC)
- Most commonly affects males, median age at diagnosis is 35 years
Pathophysiology
- Bile duct strictures impede the flow of bile, causing recurrent clinical cholangitis
- Can lead to cirrhosis and liver failure
Clinical presentation
Symptoms
- May be asymptomatic (presenting with abnormal LFTs or hepatomegaly)
- Fatigue, weight loss, fevers and sweats
Signs
Investigations
LFTs
- Cholestatic - ALP > ALT/AST, ↑ GGT and bilirubin
Imaging
- MRCP - standard procedure to visualise the intrahepatic and extrahepatic bile ducts, multiple beaded biliary strictures will be seen
- ERCP is an alternative but is invasive
Management
- Maintain bile flow - balloon dilation, stent placement
- Monitor for cholangiocarcinoma and colorectal cancer